Correction: Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation.
Main Authors: | Janela McClure, Erica S. Lovelace, Shokrollah Elahi, Nicholas J. Maurice, Jessica Wagoner, Joan Dragavon, John E. Mittler, Zane Kraft, Leonidas Stamatatos, Helen Horton, Stephen C. De Rosa, Robert W. Coombs, Stephen J. Polyak |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3491913 |
Similar Items
-
Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation.
by: Janela McClure, et al.
Published: (2012-01-01) -
Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammation.
by: Jessica Wagoner, et al.
Published: (2011-01-01) -
Correction: Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation
Published: (2012-01-01) -
Silibinin reduces cell proliferation and migration via EMT pathway in TFK-1 cell line
by: Özel Yetkin Merve, et al.
Published: (2023-12-01) -
Targeting the hallmarks of cancer: the effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer
by: Saba Sameri, et al.
Published: (2021-05-01)